Slide background
TAmiRNA – Triple A research and development of RNA diagnostics and therapeutics
Slide background
TAmiRNA – Introducing personalized medicine to Aging
Slide background
TAmiRNA – Harnessing the power of microRNAs for development of innovative diagnostic and therapeutic tools
Slide background
TAmiRNA – Helping to enhance your stability and quality of life with advanced age

partners & investors

Austria Wirtschaftsservice GmbH (AWS)

Seed and Pre-Seed financing of TAmiRNA

Die Österreichische Forschungsförderungsgesellschaft FFG

"Basisprogramm" financing of R&D cooperations of TAmiRNA.


Worldwide Distribution partner

SimplicityBio Logo


Partner in biomarker development services.

Cardiolinc Logo


Partner for collaborating on projects and translational research.


7th Framework Program EU-funded project

The SME Instrument - Horizon 2020

The SME instrument (Horizon 2020) offers seamless business innovation support from idea to market, covering the three stages of the full innovation cycle (proof-of-concept, innovation development and commercialisation).


Partner in technology and assay development for rapid microRNA quantification


Partner for assay development and functional in vitro screenings of microRNAs that are associated with age-related disorders.

Grillari Labs

Partner in development of basic research models to gain a better understanding microRNA function in age-related disorders such as Osteoporosis, Cardiovascular Disease or Neurodegenerative Disease

Evercyte GmbH

Partner in the application of pre-clinical models for toxicity and efficacy testing of novel drug candidates

Transform Science

Partner for the implementation of quality driven processes.

OK Consulting

Partner for strategic business development of TAmiRNA.